BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 13130422)

  • 1. Atypical toxoplasmic manifestation after discontinuation of maintenance therapy in a human immunodeficiency virus type 1-infected patient with immune recovery.
    Ghosn J; Paris L; Ajzenberg D; Carcelain G; Dardé ML; Tubiana R; Bossi P; Bricaire F; Katlama C
    Clin Infect Dis; 2003 Oct; 37(7):e112-4. PubMed ID: 13130422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discontinuation of primary and secondary Toxoplasma gondii prophylaxis is safe in HIV-infected patients after immunological restoration with highly active antiretroviral therapy: results of an open, randomized, multicenter clinical trial.
    Miro JM; Lopez JC; Podzamczer D; Peña JM; Alberdi JC; Martínez E; Domingo P; Cosin J; Claramonte X; Arribas JR; Santín M; Ribera E;
    Clin Infect Dis; 2006 Jul; 43(1):79-89. PubMed ID: 16758422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reactivation of retinal toxoplasmosis despite evidence of immune response to highly active antiretroviral therapy.
    Stout JE; Lai JC; Giner J; Hamilton CD
    Clin Infect Dis; 2002 Aug; 35(4):e37-9. PubMed ID: 12145740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Highly Active AntiRetroviral Therapy and opportunistic protozoan infections].
    Pozio E
    Parassitologia; 2004 Jun; 46(1-2):89-93. PubMed ID: 15305694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discontinuation of secondary prophylaxis for toxoplasmic encephalitis in human immunodeficiency virus infection after immune restoration with highly active antiretroviral therapy.
    Guex AC; Radziwill AJ; Bucher HC
    Clin Infect Dis; 2000 Mar; 30(3):602-3. PubMed ID: 10722454
    [No Abstract]   [Full Text] [Related]  

  • 6. Fetal death as a result of placental immune reconstitution inflammatory syndrome.
    Caby F; Lemercier D; Coulomb A; Grigorescu R; Paris L; Touafek F; Carcelain G; Canestri A; Pauchard M; Katlama C; Dommergues M; Tubiana R
    J Infect; 2010 Jul; 61(2):185-8. PubMed ID: 20361998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Borderline tuberculoid leprosy: an immune reconstitution phenomenon in a human immunodeficiency virus-infected person.
    Lawn SD; Wood C; Lockwood DN
    Clin Infect Dis; 2003 Jan; 36(1):e5-6. PubMed ID: 12491222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toxoplasmosis in HIV/AIDS: a living legacy.
    Nissapatorn V
    Southeast Asian J Trop Med Public Health; 2009 Nov; 40(6):1158-78. PubMed ID: 20578449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evolving characteristics of toxoplasmosis in patients infected with human immunodeficiency virus-1: clinical course and Toxoplasma gondii-specific immune responses.
    Hoffmann C; Ernst M; Meyer P; Wolf E; Rosenkranz T; Plettenberg A; Stoehr A; Horst HA; Marienfeld K; Lange C
    Clin Microbiol Infect; 2007 May; 13(5):510-5. PubMed ID: 17298486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune recovery under highly active antiretroviral therapy is associated with restoration of lymphocyte proliferation and interferon-gamma production in the presence of Toxoplasma gondii antigens.
    Fournier S; Rabian C; Alberti C; Carmagnat MV; Garin JF; Charron D; Derouin F; Molina JM
    J Infect Dis; 2001 Jun; 183(11):1586-91. PubMed ID: 11343206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recurrences of cytomegalovirus retinitis in a human immunodeficiency virus-infected patient, despite potent antiretroviral therapy and apparent immune reconstitution.
    Johnson SC; Benson CA; Johnson DW; Weinberg A
    Clin Infect Dis; 2001 Mar; 32(5):815-9. PubMed ID: 11229851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Immune reconstitution syndrome. A new disease in HIV-infected patients effectively treated with antiretroviral drugs].
    Stoll M; Behrens GM; Schmidt RE
    Dtsch Med Wochenschr; 2001 Sep; 126(37):1017-22. PubMed ID: 11555777
    [No Abstract]   [Full Text] [Related]  

  • 13. Human immunodeficiency virus type 1-related pulmonary Mycobacterium xenopi infection: a need to treat?
    Kerbiriou L; Ustianowski A; Johnson MA; Gillespie SH; Miller RF; Lipman MC
    Clin Infect Dis; 2003 Nov; 37(9):1250-4. PubMed ID: 14557971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The rate of serious bacterial infections among HIV-infected children with immune reconstitution who have discontinued opportunistic infection prophylaxis.
    Nachman S; Gona P; Dankner W; Weinberg A; Yogev R; Gershon A; Rathore M; Read JS; Huang S; Elgie C; Hudgens K; Hughes W
    Pediatrics; 2005 Apr; 115(4):e488-94. PubMed ID: 15772172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Borderline tuberculoid leprosy with upgrading Type 1 reaction in a HIV seropositive patient, after antiretroviral therapy: an immune reconstitution inflammatory syndrome.
    Kar HK; Sharma P; Bhardwaj M
    Lepr Rev; 2009 Mar; 80(1):85-8. PubMed ID: 19472856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discontinuation of secondary prophylaxis against disseminated Mycobacterium avium complex infection and toxoplasmic encephalitis.
    Zeller V; Truffot C; Agher R; Bossi P; Tubiana R; Caumes E; Jouan M; Bricaire F; Katlama C
    Clin Infect Dis; 2002 Mar; 34(5):662-7. PubMed ID: 11810599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tegumentary leishmaniasis as a manifestation of immune reconstitution inflammatory syndrome in 2 patients with AIDS.
    Posada-Vergara MP; Lindoso JA; Tolezano JE; Pereira-Chioccola VL; Silva MV; Goto H
    J Infect Dis; 2005 Nov; 192(10):1819-22. PubMed ID: 16235183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How infrequent are opportunistic diseases and immune reconstitution syndromes among HIV-infected individuals who have favorable CD4+ cell count responses to antiretroviral therapy?
    Phillips P
    Clin Infect Dis; 2005 May; 40(9):1379-80; author reply 1380-1. PubMed ID: 15825049
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effect of opportunistic infections on the frequency of leukocyte subpopulations from type-1 human immunodeficiency virus infected individuals].
    Ramírez Z; Cataño JC; Román A; Rugeles MT; Montoya CJ
    Biomedica; 2008 Mar; 28(1):64-77. PubMed ID: 18645662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Seroprevalence of toxoplasmosis in HIV infected patients in Pondicherry.
    Shivaprakash MR; Parija SC; Sujatha S
    J Commun Dis; 2001 Sep; 33(3):221-3. PubMed ID: 12206044
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.